JP2024527620A5 - - Google Patents
Info
- Publication number
- JP2024527620A5 JP2024527620A5 JP2024502131A JP2024502131A JP2024527620A5 JP 2024527620 A5 JP2024527620 A5 JP 2024527620A5 JP 2024502131 A JP2024502131 A JP 2024502131A JP 2024502131 A JP2024502131 A JP 2024502131A JP 2024527620 A5 JP2024527620 A5 JP 2024527620A5
- Authority
- JP
- Japan
- Prior art keywords
- csc
- tap
- cancer
- molecule
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163203320P | 2021-07-16 | 2021-07-16 | |
| US63/203,320 | 2021-07-16 | ||
| PCT/CA2022/051068 WO2023023840A1 (en) | 2021-07-16 | 2022-07-07 | Novel tumor-specific antigens for cancer stem cells and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527620A JP2024527620A (ja) | 2024-07-25 |
| JP2024527620A5 true JP2024527620A5 (https=) | 2025-07-11 |
Family
ID=85322248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502131A Pending JP2024527620A (ja) | 2021-07-16 | 2022-07-07 | がん幹細胞に対する新規の腫瘍特異的抗原及びそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240382590A1 (https=) |
| EP (1) | EP4370682A4 (https=) |
| JP (1) | JP2024527620A (https=) |
| AU (1) | AU2022331944A1 (https=) |
| CA (1) | CA3224907A1 (https=) |
| WO (1) | WO2023023840A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2347769A1 (en) * | 2010-01-20 | 2011-07-27 | Glycotope GmbH | Cancer stem cell markers and uses thereof |
| CN112639136B (zh) * | 2018-08-30 | 2024-08-02 | 蒙特利尔大学 | 用于鉴定肿瘤特异性抗原的基于蛋白质基因组学的方法 |
| BR112021025943A2 (pt) * | 2019-06-25 | 2022-02-08 | Univ Montreal | Antígenos específicos de tumor inovadores para câncer de ovário e usos dos mesmos |
-
2022
- 2022-07-07 US US18/579,831 patent/US20240382590A1/en active Pending
- 2022-07-07 JP JP2024502131A patent/JP2024527620A/ja active Pending
- 2022-07-07 CA CA3224907A patent/CA3224907A1/en active Pending
- 2022-07-07 EP EP22859725.8A patent/EP4370682A4/en active Pending
- 2022-07-07 AU AU2022331944A patent/AU2022331944A1/en active Pending
- 2022-07-07 WO PCT/CA2022/051068 patent/WO2023023840A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Barzaman et al. | Breast cancer immunotherapy: Current and novel approaches | |
| Liu et al. | mRNA cancer vaccines: construction and boosting strategies | |
| Yao et al. | Recent progress in mRNA cancer vaccines | |
| JP7005346B2 (ja) | 養子細胞免疫療法の有効性を増強させるための組成物および方法 | |
| ES2835269T5 (en) | Claudin-18.2-specific immunoreceptors and t cell epitopes | |
| CN104140974B (zh) | 编码gpc‑3嵌合抗原受体蛋白的核酸及表达gpc‑3嵌合抗原受体蛋白的t淋巴细胞 | |
| CN104087607B (zh) | 编码嵌合抗原受体蛋白的核酸及表达嵌合抗原受体蛋白的t淋巴细胞 | |
| CN106146666B (zh) | 靶向cldn6的免疫效应细胞及其制备方法和应用 | |
| JP2021522820A5 (https=) | ||
| US20190298715A1 (en) | Immune effector cell therapies with enhanced efficacy | |
| JP6621473B2 (ja) | 癌の診断および処置のための方法および組成物 | |
| WO2015172339A1 (zh) | 编码嵌合抗原受体蛋白的核酸及表达嵌合抗原受体蛋白的t淋巴细胞 | |
| CN105194661A (zh) | 时空可调性抑制病理性靶细胞的系统 | |
| JP2023518396A5 (https=) | ||
| JP2024535853A5 (https=) | ||
| JP2020533962A5 (https=) | ||
| CN110352067A (zh) | Hla限制性vgll1肽及其用途 | |
| WO2022057941A1 (zh) | 表达il-7r结合蛋白的免疫效应细胞 | |
| CN114599400A (zh) | 用于治疗癌症的医药、组合医药、医药组合物、免疫应答细胞、核酸递送介质和制品 | |
| Roesler et al. | Beyond sequencing: prioritizing and delivering neoantigens for cancer vaccines | |
| Afzal et al. | Current trends in messenger RNA technology for cancer therapeutics | |
| JP2023521219A5 (https=) | ||
| JP2024527620A5 (https=) | ||
| CN110331134A (zh) | 一种表达抗原识别区域的通用型细胞治疗产品及其制备方法和应用 | |
| JP2021517454A5 (https=) |